DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20161527

Pharmacovigilance studies on the basic knowledge, practice and attitude among the second year MBBS students of Jawaharlal Nehru institute of medical sciences, Porompat, Manipur, India

Varkung Valte, Babycha Laishram, Premchand M. Singh, Indira Raleng

Abstract


Background: The recent advancement in the field of Medicine and Pharmaceutical sciences, the adverse effects of Medicine is a challenge among the medical fraternity. The objective of this study was to study the knowledge, Practice and attitude of ADRs among the second year MBBS students with the aim to find out the means for implementation of pharmacovigilance programme of India (PvPi).

Methods: The pretested questionnaire on knowledge, practice, attitude on Pharmacovigilance. The design of the study is cross sectional study. Percentage, proportions and means are used for descriptive statistics while the associations are calculated using corresponding tests for the associations.

Results: The knowledge of the students on pharmacovigilance in connection with over the counter/self-medication(52%); minimum need of surveillance on marketing(74%); present surveillance on marketing 60%; need of CME on ADRs along with pharmacovigilance among student (64%) as the ADRs on elderly (57%), children (58%), Pregnancy (64%). Out of 24 questions on attitude, only 7 questions on reporting, multinational company, drug controller of India, disability and compensation are selected for statistical analysis. The percentage of the students who has heard and seen ADRs is 64.5.

Conclusions: If there is good communication and reports; most of the ADRs are avoidable and plays a pivotal role in minimising the ADRs. Drugs must be prescribed rationally and poly pharmacy should be discouraged and avoided as much as possible. To avoid the ADRs, pharmacovigilance is a matter of great concern for the health care providers and for the general mass too.


Keywords


PvPi, ADRs, UMC-WHO, CME, OTC, DC- I, MNC

Full Text:

PDF

References


Tripathi KD. Adverse drug effects: - Essential of medical pharmacology, 7th edition; 2013:82-83.

Bennett PN, Brown MJ. Unwanted effects and adverse drug reactions; Clinical pharmacology. 9th edtion; 2003:135-150.

Hardman JG, Limbird LE, Gilman AG. Principles of therapeutic, the pharmacological basis of therapeutic. 10th Edition; 2001:45-66.

Laurence DR, Bacharach AL. Toxicity tests; evaluation of drug activities; pharmacometrics. 2011;1:135-66.

Gaitonde BB, Telang BV. Drug toxicity and drug interactions. Basic and clinical pharmacology and therapeutics; 2010:42-50.

Gosh MN. Statistical analysis; fundamentals of experimental pharmacology 3rd edi.; 2005:218-229.

National pharmacovigilance protocol, MOHFW, GOI.

MW Ahmed, Vardhamane SH, Dass P, Ahmed R, Gulabani M. Knowledge, attitude and practice of pharmacovigilance in baseveshwar teaching and general hospital: Journal of evolution of medicine and dental science. 2014;13(24):6698-707.

Park K. Text book of preventive and social medicine, 23rd edition; 2015:72-79.